RecruitingNot ApplicableNCT06512974
NeuroTrainer Cognitive Training For Academic Focus
A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties
Sponsor
NeuroTrainer
Enrollment
155 participants
Start Date
Sep 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
Eligibility
Min Age: 11 YearsMax Age: 17 Years
Inclusion Criteria3
- Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe
- Estimated IQ of 80 or greater
- Between 11-17 years of age
Exclusion Criteria4
- Presence of suicidality
- Presence of psychotic disorders
- Visual or hearing impairment
- Presence of severe depression
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALNeuroTrainer
Virtual reality based cognitive training
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06512974
Related Trials
Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
NCT047819721 location
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
NCT062991891 location
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
NCT060813488 locations
Methylphenidate in KBG Syndrome: N-of-1 Series
NCT064656411 location